Report
The Economics of Genomic Medicine - Workshop Summary
- Released:
- March 26, 2013
- Type:
- Workshop Summary
- Topics:
- Biomedical and Health Research, Public Health
- Activity:
- Roundtable on Translating Genomic-Based Research for Health
- Board:
- Board on Health Sciences Policy
Note: Workshop Summaries contain the opinion of the presenters, but do NOT reflect the conclusions of the IOM. Learn more about the differences between Workshop Summaries and Consensus Reports.
The sequencing of the human genome and the identification of links between specific genetic variants and diseases have led to tremendous excitement over the potential of genomics to direct patient treatment toward more effective or less harmful interventions. However, stakeholders disagree on whether our current understanding of genomic information is ready for clinical use. Additionally, some stakeholders are concerned that genomic technologies will add costs to the health care system without providing commensurate benefits, while others think that health care costs could be reduced by identifying unnecessary or ineffective treatments.
Economic models are frequently used to anticipate the costs and benefits of new health care technologies, policies, and regulations. However, health economic assessments are often limited by a lack of data on which to base the examination.
To better understand the health economic issues that may arise in the course of integrating genomic data into health care, the IOM Roundtable on Translating Genomic-Based Research for Health hosted a workshop July 17-18, 2012, that brought together economists, regulators, payers, biomedical researchers, patients, providers, and others to discuss the many factors that may influence this implementation.
For additional resources, such as the agenda and presentations, please visit the workshop page.
Economic models are frequently used to anticipate the costs and benefits of new health care technologies, policies, and regulations. However, health economic assessments are often limited by a lack of data on which to base the examination.
To better understand the health economic issues that may arise in the course of integrating genomic data into health care, the IOM Roundtable on Translating Genomic-Based Research for Health hosted a workshop July 17-18, 2012, that brought together economists, regulators, payers, biomedical researchers, patients, providers, and others to discuss the many factors that may influence this implementation.
For additional resources, such as the agenda and presentations, please visit the workshop page.
No hay comentarios:
Publicar un comentario